Campbell & Co Investment Adviser’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$803K Buy
+9,418
New +$839K 0.05% 582
2025
Q4
Sell
-17,546
Closed -$1.4M 1159
2025
Q3
$1.4M Buy
+17,546
New +$1.5M 0.11% 290
2025
Q1
Sell
-17,236
Closed -$1.57M 1066
2024
Q4
$1.57M Buy
+17,236
New +$1.64M 0.12% 248
2023
Q1
Sell
-15,644
Closed -$1.23M 834
2022
Q4
$1.23M Buy
+15,644
New +$1.17M 0.29% 57
2021
Q2
Sell
-3,178
Closed -$251K 547
2021
Q1
$251K Buy
+3,178
New +$249K 0.15% 281
2017
Q1
Sell
-3,842
Closed -$251K 160
2016
Q4
$251K Buy
+3,842
New +$263K 0.78% 57
2015
Q1
Sell
-16,900
Closed -$1.17M 207
2014
Q4
$1.17M Buy
+16,900
New +$1.14M 0.72% 41

Other funds holding CL

Campbell & Co Investment Adviser's CL Position: Q1 2026 in Review

Campbell & Co Investment Adviser opened a new position in Colgate-Palmolive (CL) in Q1 2026: 9,418 shares worth $803K. The stake represents 0.05% of the portfolio and ranks #582 among its holdings. This is a return to the name: Campbell & Co Investment Adviser previously reported a position in CL as recently as Q3 2025.

Campbell & Co Investment Adviser first reported a position in CL in Q4 2014 and has held it in 7 quarters since. The position peaked at $1.57M in Q4 2024. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Campbell & Co Investment Adviser held 9,418 shares of Colgate-Palmolive worth $803K as of Q1 2026.
  • Colgate-Palmolive was a new Campbell & Co Investment Adviser position in Q1 2026.
  • Colgate-Palmolive made up 0.05% of Campbell & Co Investment Adviser's portfolio in Q1 2026, its #582 holding.
  • Campbell & Co Investment Adviser first reported a position in Colgate-Palmolive in Q4 2014 and has held it in 7 quarters since.
  • Campbell & Co Investment Adviser's Colgate-Palmolive position peaked at $1.57M in Q4 2024.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q1 2026, filed 15 May 2026.